Quantum Genesis AI Corp. (QGAI)

Market Cap	7.37M
Revenue (ttm)	n/a
Net Income	-4.49M
EPS	-0.12
Shares Out	40.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,057
Average Volume	15,007
Open	0.1000
Previous Close	0.0850
Day's Range	0.1000 - 0.1800
52-Week Range	0.0025 - 5.0400
Beta	11.52
RSI	47.42
Earnings Date	Jun 16, 2026

About Quantum Genesis AI

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. w...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2015
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: QGAI